Resources
Learn more about the quest for shorter, faster, and more effective TB cures; share with your friends, family, and colleagues!
A variety of resources can be found on this page. Click the handy headers to help navigate the resource library.
Community Friendly Resources
Use and share Fast Track the Cure and partners’ community friendly resources to learn and take effective and rapid action in support of access to safer, shorter, and more effective treatments!
Here you will find ready made messages and images for joining #6MonthsMax on social media!
Shorter all-oral DR-TB Regimen Training Manual
Use GCTA’s 2-day training manual to provide the community with treatment literacy and advocacy skills to generate demand for BPaL and BPaLM.
In this comic developed by team YKI in Indonesia, you can follow the story of Izmi who was cured of DR-TB using the new #6MonthsMax treatment regimen!
Videos
View and share Fast Track the Cure video stories and calls for #6MonthsMax treatments for all! See and learn from our full video playlist on YouTube here.
Joi from the Philippines shares his first hand experience of being treated for drug resistant TB and eventually cured with the new novel all-oral regimens.
Essential Readings
Learn more about new #6MonthsMax treatment regimens for drug-resistant Tuberculosis from these essential readings.
Bedaquiline–Pretomanid–Linezolid Regimens for Drug-Resistant Tuberculosis (NEJM)
To limit toxic effects and improve quality of life, following the Nix-TB trial TB Alliance conducted the ZeNix trial, which showed the dose of linezoid could be reduced to improve tolerability and safety of the new 6 month regimen without compromising its efficacy.
These World Health Organization guidelines inform health care professionals on how to improve treatment and care for patients with drug-resistant TB (DR-TB). This document includes a new recommendation for the use of the new 6-month regimen for treating DR-TB.
Savings from the introduction of BPaL and BPaLM regimens at the country level (IJTLD)
Forecasts found that when the previous 9-21 month treatment regimens were replaced with BPaL/BPaLM, the savings per person treated in Pakistan, the Philippines, South Africa, and Ukraine were between $746 and $2,636; health systems could save between 15%-60% by scaling up six-month treatments over the next five years.
Assets from the aligned 1/4/6x24 Campaign
The 1/4/6×24 Campaign is an aligned initiative being prioritized by TB stakeholders and partners around the world. It’s central demand seeks to catalyze into meaningful action recent scientific progress enabling safer, shorter cures recommended by the WHO for nearly all forms of TB: one month or once-weekly regimens for TB prevention, four-month regimens for drug-sensitive TB, and six-month regimens for drug-resistant TB – by the end of 2024.
This presentation from TAG and partners details what you need to know about the 6 (BPaL/M) and how to engage in the 1/4/6x24 campaign!
An Activist’s Guide to Shorter Treatment for Drug-Resistant Tuberculosis
This new Activist’s Guide to Shorter Treatment for Drug-Resistant Tuberculosis lays out everything advocates need to know about the six-month regimens, including important considerations for key populations affected by TB.
Ani Herna Sari explains why we need access to shorter, safer TB regimens
(Treatment Action Group)